Literature DB >> 8428596

Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15.

C H McGowan1, P Russell.   

Abstract

In fission yeast, the M-phase inducing kinase, a complex of p34cdc2 and cyclin B, is maintained in an inhibited state during interphase due to the phosphorylation of Cdc2 at Tyr15. This phosphorylation is believed to be carried out primarily by the Wee1 kinase. In human cells the negative regulation of p34cdc2/cyclin B is more complex, in that Cdc2 is phosphorylated at two inhibitory sites, Thr14 and Tyr15. The identities of the kinases that phosphorylate these sites are unknown. Since fission yeast Wee1 kinase behaves as a dual-specificity kinase in vitro, a popular hypothesis is that a human Wee1 homolog might phosphorylate p34cdc2 at both sites. We report here that a human gene, identified as a possible Wee1 homologue, blocks cell division when overexpressed in HeLa cells. This demonstrates functional conservation of the Wee1 mitotic inhibitor. Contrary to the dual-specificity kinase hypothesis, purified human Wee1 phosphorylates p34cdc2 exclusively on Tyr15 in vitro; no Thr14 phosphorylation was detected. Human and fission yeast Wee1 also specifically phosphorylate synthetic peptides at sites equivalent to Tyr15. Mutation of a critical lysine codon (Lys114) believed to be essential for kinase activity abolished both the in vivo mitotic inhibitor function and in vitro kinase activities of human Wee1. These results conclusively prove that Wee1 kinases inhibit mitosis by directly phosphorylating p34cdc2 on Tyr15, and strongly indicate that human cells have independent kinase pathways directing the two inhibitor phosphorylations of p34cdc2.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8428596      PMCID: PMC413177          DOI: 10.1002/j.1460-2075.1993.tb05633.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  46 in total

1.  Genetic control of cell size at cell division in yeast.

Authors:  P Nurse
Journal:  Nature       Date:  1975-08-14       Impact factor: 49.962

Review 2.  The cdc25 M-phase inducer: an unconventional protein phosphatase.

Authors:  J B Millar; P Russell
Journal:  Cell       Date:  1992-02-07       Impact factor: 41.582

3.  Regulation of the cdc25 protein during the cell cycle in Xenopus extracts.

Authors:  A Kumagai; W G Dunphy
Journal:  Cell       Date:  1992-07-10       Impact factor: 41.582

4.  The cdc25 protein contains an intrinsic phosphatase activity.

Authors:  W G Dunphy; A Kumagai
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

5.  Negative regulation of mitosis by wee1+, a gene encoding a protein kinase homolog.

Authors:  P Russell; P Nurse
Journal:  Cell       Date:  1987-05-22       Impact factor: 41.582

6.  Protein phosphatase-1 and protein phosphatase-2A from rabbit skeletal muscle.

Authors:  P Cohen; S Alemany; B A Hemmings; T J Resink; P Strålfors; H Y Tung
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

7.  Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2.

Authors:  K Sadhu; S I Reed; H Richardson; P Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

8.  Complementation of the mitotic activator, p80cdc25, by a human protein-tyrosine phosphatase.

Authors:  K L Gould; S Moreno; N K Tonks; P Nurse
Journal:  Science       Date:  1990-12-14       Impact factor: 47.728

9.  Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2.

Authors:  M G Lee; P Nurse
Journal:  Nature       Date:  1987 May 7-13       Impact factor: 49.962

10.  Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells.

Authors:  C V Hall; P E Jacob; G M Ringold; F Lee
Journal:  J Mol Appl Genet       Date:  1983
View more
  157 in total

1.  DNA damage and replication checkpoints in fission yeast require nuclear exclusion of the Cdc25 phosphatase via 14-3-3 binding.

Authors:  Y Zeng; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  The G(2) checkpoint is maintained by redundant pathways.

Authors:  T M Passalaris; J A Benanti; L Gewin; T Kiyono; D A Galloway
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

3.  Overproduction of human Myt1 kinase induces a G2 cell cycle delay by interfering with the intracellular trafficking of Cdc2-cyclin B1 complexes.

Authors:  F Liu; C Rothblum-Oviatt; C E Ryan; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

4.  Influence of the G2 cell cycle block abrogator pentoxifylline on the expression and subcellular location of cyclin B1 and p34cdc2 in HeLa cervical carcinoma cells.

Authors:  T Theron; L Böhm
Journal:  Cell Prolif       Date:  2000-02       Impact factor: 6.831

5.  Specific down-regulation of annexin II expression in human cells interferes with cell proliferation.

Authors:  Y Chiang; A Rizzino; Z A Sibenaller; M S Wold; J K Vishwanatha
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

6.  The Aspergillus nidulans snt genes are required for the regulation of septum formation and cell cycle checkpoints.

Authors:  P R Kraus; S D Harris
Journal:  Genetics       Date:  2001-10       Impact factor: 4.562

7.  Cyclin E deregulation impairs mitotic progression through premature activation of Cdc25C.

Authors:  Rozita Bagheri-Yarmand; Angela Nanos-Webb; Anna Biernacka; Tuyen Bui; Khandan Keyomarsi
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

8.  Hyperphosphorylation by cyclin B/CDK1 in mitosis resets CUX1 DNA binding clock at each cell cycle.

Authors:  Laurent Sansregret; David Gallo; Marianne Santaguida; Lam Leduy; Ryoko Harada; Alain Nepveu
Journal:  J Biol Chem       Date:  2010-08-19       Impact factor: 5.157

9.  Functional analysis of the Drosophila CDC2 Dm gene in fission yeast.

Authors:  E R Bejarano; M J Muñoz; J Jimenez
Journal:  Mol Gen Genet       Date:  1995-09-20

10.  A link between MAP kinase and p34(cdc2)/cyclin B during oocyte maturation: p90(rsk) phosphorylates and inactivates the p34(cdc2) inhibitory kinase Myt1.

Authors:  A Palmer; A C Gavin; A R Nebreda
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.